Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Maternal immunization against viral disease

J Englund1, W P Glezen, P A Piedra

  • 1Department of Microbiology, Baylor College of Medicine, Houston, TX 77030, USA. jenglund@bcm.tmc.edu

Vaccine
|August 26, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nasopharyngeal CCL5 in infants with severe bronchiolitis and risk of recurrent wheezing: A multi-center prospective cohort study.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2018
Same author

The relationship between nasopharyngeal CCL5 and microbiota on disease severity among infants with bronchiolitis.

Allergy·2017
Same author

[Universal immunisation against influenza in paediatrics, yes or no?].

Anales de pediatria (Barcelona, Spain : 2003)·2013
Same author

Influenza surveillance in an urban area.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same author

Vaccination of hematopoietic cell transplant recipients.

Bone marrow transplantation·2009
Same author

Maternal immunization with Haemophilus influenzae type b vaccines in different populations.

Vaccine·2003
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026
Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026
See all related articles

Maternal immunization offers a promising strategy to protect infants from viral diseases. This approach leverages maternal antibodies and vaccination during pregnancy for enhanced infant immunity.

Area of Science:

  • Immunology
  • Vaccinology
  • Maternal-Fetal Medicine

Background:

  • Maternal antibodies provide crucial protection against viral infections in infants.
  • Infants are highly susceptible to diseases but have immature immune responses.
  • Maternal immunization during pregnancy is a potential strategy to enhance infant immunity.

Purpose of the Study:

  • To review the benefits and risks of maternal immunization for infant protection against viral diseases.
  • To explore the safety and immunogenicity of specific maternal vaccines.
  • To identify potential viral pathogens for future maternal vaccination strategies.

Main Methods:

  • Literature review of existing studies on maternal immunization.
  • Analysis of safety and immunogenicity data from trials involving pregnant or postpartum women.

Related Experiment Videos

  • Examination of antibody transfer mechanisms (placental and breast milk).

    • Main Results:

    • Maternal immunization can safely induce protective antibodies in infants via placental transfer and breast milk.
    • Vaccines for poliovirus, influenza, and rubella have demonstrated safety in pregnant women.
    • A respiratory syncytial virus (RSV) vaccine showed safety and immunogenicity in postpartum women, with antibodies detected in breast milk.

    Conclusions:

    • Maternal immunization is a viable strategy to protect infants from viral pathogens.
    • Further research is essential to establish the safety and efficacy of maternal vaccination against neonatal viral infections.
    • Consideration should be given to vaccines targeting respiratory syncytial virus, parainfluenza viruses, herpesviruses, and HIV.